Early adolescence is associated with high rates of experimental inhalant misuse, but only a minority continue to inhale on a regular basis.
Inhalant misuse is associated with a range of adverse outcomes, including reports of increased morbidity and mortality.
Research into inhalant use among adolescents is lacking, with limited data available on long‐term outcomes or evidence‐based approaches to treatment.
Legislative and supply‐reduction strategies have been introduced by a number of states and territories over recent years, but direct funding for specific targeted interventions is lacking.
Investment and commitment to a national research framework, as well as coordination of local services, is urgently required.